Clinical Trials Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy 12 Jan 2021
MaxCyte starts dosing in Phase I trial of MCY-M11 MaxCyte has dosed the first patient in a Phase I clinical trial to evaluate the... 11th October 2018